The epidemiology of invasive pneumococcal disease in the Canadian North from 1999 to 2010

International Journal of Circumpolar Health

Volumn 72, Issue SUPPL.1, 2013, Pages

  Helferty, Melissa ^a   Rotondo, Jenny L ^a   Martin, Irene ^b   Desai, Shalini ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Canadian circumpolar region; Epidemiology; Streptococcus pneumoniae; Surveillance; Vaccine preventable disease

Indexed keywords

ANTIINFECTIVE AGENT; PNEUMOCOCCUS VACCINE; VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARCTIC; CANADA; CHILD; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; GENETICS; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; INUIT; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; NEWBORN; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; SOCIOECONOMICS; STREPTOCOCCUS PNEUMONIAE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARCTIC REGIONS; CANADA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INUITS; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE; SOCIOECONOMIC FACTORS; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE; YOUNG ADULT;

EID: 84881266026     PISSN: 12399736     EISSN: 22423982     Source Type: Journal    
DOI: 10.3402/ijch.v72i0.21606     Document Type: Article

References (12)

1. Parkinson AJ, Bruce MG, Zulz T and the International Circumpolar Surveillance Steering Committee. International Circumpolar Surveillance, an arctic network for the surveillance of infectious diseases. Emerg Infect Dis. 2008;14:18-24.
2. Heymann DL. Control of communicable diseases manual, 19th ed. Washington: American Public Health Association; 2008.
3. Vaudry W, Talling D. Invasive pneumococcal infection in First Nations children in northern Alberta. Can Commun Dis Rep. 2002;28:165-72.
4. Scheifele D, Law B, Vaudry W, Halperin S, Kellner J, King A, et al. Invasive pneumococcal infections among Canadian aboriginal children. Can Commun Dis Rep. 2003;29:37-42.
5. National Advisory Committee on Immunization. Update on the use of conjugate pneumococcal vaccines in childhood. Can Commun Dis Rep. 2010;36(ACS-12):1-21.
6. Bruce MG, Deeks SL, Zulz T, Bruden D, Navarro C, Lovgren M, et al. International Circumpolar Surveillance System for invasive pneumococcal disease, 1999-2005. Emerg Infect Dis. 2008;14:25-33.
7. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 9th ed., M07-A9. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute; 2013.
9. Public Health Agency of Canada. Vaccine-preventable diseases: invasive pneumococcal disease [cited 2012 Nov 27]. Available from: http://www.phac-aspc.gc.ca/im/vpd-mev/pneumococcaleng. php
10. Hennessy TW, Singleton RJ, Bulkow LR, Bruden DL, Hurlburt DA, Parks D, et al. Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity. Vaccine. 2005;23: 5464-73.
11. Hanna JN, Humphreys JL, Murphy DM. Invasive pneumococcal disease in Indigenous people in north Queensland: an update, 2005-2007. Med J Aust. 2008;189:43-6.
12. Public Health Agency of Canada. Canadian National Report on Immunization. Canada Communicable Disease Report. 2006;32S3:8.